PLRX
Pliant Therapeutics·NASDAQ
--
--(--)
--
--(--)
PLRX fundamentals
Pliant Therapeutics (PLRX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.71 (YoY +22.83%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.71
+22.83%
Report date
Aug 7, 2025
EPS
Actual | -1.39 | -0.47 | -0.54 | -0.64 | -0.64 | -0.75 | -0.68 | -0.78 | -0.82 | -0.65 | -0.72 | -0.67 | -0.7 | -0.7 | -0.69 | -0.78 | -0.92 | -0.95 | -0.82 | -0.92 | -0.71 |
Forecast | -0.8583 | -0.8486 | -0.7124 | -0.6047 | -0.6702 | -0.6904 | -0.7607 | -0.7494 | -0.8124 | -0.7412 | -0.7 | -0.6683 | -0.7132 | -0.7753 | -0.8135 | -0.7718 | -0.8486 | -0.9692 | -0.9564 | -0.7668 | -0.6772 |
Surprise | -61.95% | +44.61% | +24.20% | -5.84% | +4.51% | -8.63% | +10.61% | -4.08% | -0.94% | +12.30% | -2.86% | -0.25% | +1.85% | +9.71% | +15.18% | -1.06% | -8.41% | +1.98% | +14.26% | -19.98% | -4.84% |
Revenue
Actual | 3.60M | 4.81M | 4.46M | 2.17M | 1.79M | 1.61M | 2.00M | 1.25M | 4.99M | 1.48M | 1.97M | 1.33M | 248.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 3.70M | 2.50M | 3.37M | 4.23M | 4.17M | 3.17M | 3.00M | 1.26M | 1.35M | 1.79M | 1.45M | 1.39M | 1.21M | 1.02M | 814.11K | 580.63K | 732.50K | 472.22K | 0 | 0 | 0 |
Surprise | -2.70% | +92.56% | +32.62% | -48.65% | -57.06% | -49.16% | -33.37% | -0.87% | +269.59% | -17.32% | +35.46% | -4.02% | -79.55% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Pliant Therapeutics year over year?Did Pliant Therapeutics beat or miss consensus estimates last quarter?What does Pliant Therapeutics do and what are its main business segments?What guidance did Pliant Therapeutics's management provide for the next earnings period?What is Pliant Therapeutics's gross profit margin?What were the key takeaways from Pliant Therapeutics's earnings call?What were the key takeaways from Pliant Therapeutics’s earnings call?What factors drove the changes in Pliant Therapeutics's revenue and profit?
